Tonix Pharmaceuticals Announces Publication of Data in the Journal Nature Involving TNX-1500 (Fc-modified dimeric anti-CD40L mAb) for the Prevention of Rejection in Kidney Xenotransplantation in Animal Models
October 18, 2023 07:00 ET
|
Tonix Pharmaceuticals Holding Corp.
Research Directed by Faculty of the Center for Transplantation Sciences, Massachusetts General Hospital TNX-1500 is Enrolling in a Phase 1 Clinical Trial Tonix is Developing TNX-1500 for Prevention...
IBA signe un contrat pour la modernisation de son premier système de protonthérapie
October 18, 2023 01:00 ET
|
IBA SA
Actualisation complète de la machine historique offrant une opportunité de solution durable Louvain-la-Neuve, Belgique, le 18 octobre 2023 - IBA (Ion Beam Applications S.A., EURONEXT), le leader...
IBA plans total system restoration on its first-ever proton therapy installation
October 18, 2023 01:00 ET
|
IBA SA
Comprehensive restoration of legacy machine offers the opportunity for sustainable solution Louvain-La-Neuve, Belgium, October 18, 2023 – IBA (Ion Beam Applications S.A., EURONEXT), the world leader...
The Southport School & The Southport CoLAB to Host Simulcast of The Dyslexia Foundation Conference
October 02, 2023 12:15 ET
|
The Southport School Inc
SOUTHPORT, Conn., Oct. 02, 2023 (GLOBE NEWSWIRE) -- The Southport School, an independent day school for cerebrodiverse children in grades 2-8 with language-based learning differences as well as...
Replay announces partnership between product company Syena and JURA Bio to advance T cell receptor NK therapies in cancer
September 21, 2023 08:00 ET
|
Replay Bio
Replay announces partnership between product company Syena and JURA Bio to advance T cell receptor NK therapies in cancer Collaboration leverages JURA Bio’s T cell receptor (TCR) discovery platform...
Axsome Therapeutics Highlights Commitment to Innovating Treatments for Mental Health Conditions with Presentations at Psych Congress 2023
September 07, 2023 07:03 ET
|
Axsome Therapeutics, Inc.
Data presentations explore effects on patient-centric efficacy measures of treatments for patients with depression, and excessive sleepiness associated with obstructive sleep apnea and narcolepsy NEW...
Radioactive Tracer Market Worth $54.29 Billion by 2030 - Exclusive Report by The Insight Partners
August 16, 2023 08:32 ET
|
The Insight Partners
Pune, India, Aug. 16, 2023 (GLOBE NEWSWIRE) -- A radioactive tracer is a chemical compound in which one or more atoms have been replaced by a radioisotope. Through monitoring its radioactive decay,...
Tonix Pharmaceuticals Reports Second Quarter 2023 Financial Results and Operational Highlights
August 10, 2023 16:30 ET
|
Tonix Pharmaceuticals Holding Corp.
Topline Results from Four CNS Clinical Trials Expected in the Third and Fourth Quarters of 2023 Fibromyalgia Topline Results Expected in the Fourth Quarter of 2023 for Phase 3 Potentially...
World Lab-on-a-Chip & Microfluidics Congress 2023: Where Innovations Meet Applications (Laguna Hills, United States - November 28-30, 2023)
August 02, 2023 07:33 ET
|
Research and Markets
Dublin, Aug. 02, 2023 (GLOBE NEWSWIRE) -- The "Lab-on-a-Chip & Microfluidics World Congress 2023" conference has been added to ResearchAndMarkets.com's offering. Welcome to the 16th Annual...